Susquehanna International Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $329M | Sell |
670,100
-477,600
| -42% | -$259M | 0.04% | 358 |
|
|
2025
Q4 | $665M | Sell |
1,147,700
-11,700
| -1% | -$6.62M | 0.08% | 202 |
|
|
2025
Q3 | $562M | Buy |
1,159,400
+158,700
| +16% | +$73.9M | 0.06% | 238 |
|
|
2025
Q2 | $406M | Buy |
1,000,700
+316,700
| +46% | +$132M | 0.06% | 256 |
|
|
2025
Q1 | $340M | Sell |
684,000
-16,600
| -2% | -$8.99M | 0.06% | 263 |
|
|
2024
Q4 | $364M | Buy |
700,600
+145,100
| +26% | +$79.8M | 0.06% | 258 |
|
|
2024
Q3 | $344M | Sell |
555,500
-27,200
| -5% | -$16.1M | 0.06% | 265 |
|
|
2024
Q2 | $322M | Buy |
582,700
+176,200
| +43% | +$101M | 0.06% | 241 |
|
|
2024
Q1 | $236M | Sell |
406,500
-398,700
| -50% | -$224M | 0.04% | 369 |
|
|
2023
Q4 | $427M | Buy |
805,200
+114,400
| +17% | +$55.4M | 0.08% | 198 |
|
|
2023
Q3 | $350M | Sell |
690,800
-124,800
| -15% | -$66.5M | 0.07% | 211 |
|
|
2023
Q2 | $426M | Buy |
815,600
+17,300
| +2% | +$9.34M | 0.09% | 165 |
|
|
2023
Q1 | $460M | Buy |
798,300
+70,300
| +10% | +$39.6M | 0.1% | 156 |
|
|
2022
Q4 | $401M | Buy |
728,000
+121,500
| +20% | +$64.4M | 0.1% | 164 |
|
|
2022
Q3 | $308M | Buy |
606,500
+256,200
| +73% | +$143M | 0.08% | 186 |
|
|
2022
Q2 | $190M | Sell |
350,300
-30,000
| -8% | -$16.5M | 0.05% | 317 |
|
|
2022
Q1 | $225M | Sell |
380,300
-288,000
| -43% | -$165M | 0.04% | 369 |
|
|
2021
Q4 | $446M | Sell |
668,300
-226,500
| -25% | -$141M | 0.07% | 235 |
|
|
2021
Q3 | $519M | Buy |
894,800
+361,800
| +68% | +$199M | 0.07% | 227 |
|
|
2021
Q2 | $271M | Buy |
533,000
+100,100
| +23% | +$47.2M | 0.04% | 384 |
|
|
2021
Q1 | $198M | Sell |
432,900
-58,600
| -12% | -$28M | 0.03% | 450 |
|
|
2020
Q4 | $229M | Buy |
491,500
+269,300
| +121% | +$126M | 0.04% | 382 |
|
|
2020
Q3 | $98.1M | Buy |
222,200
+60,900
| +38% | +$25.2M | 0.02% | 575 |
|
|
2020
Q2 | $58.4M | Sell |
161,300
-138,800
| -46% | -$46.5M | 0.01% | 745 |
|
|
2020
Q1 | $85.1M | Buy |
300,100
+190,700
| +174% | +$60.1M | 0.03% | 452 |
|
|
2019
Q4 | $35.5M | Sell |
109,400
-12,600
| -10% | -$3.82M | 0.01% | 1014 |
|
|
2019
Q3 | $35.5M | Buy |
122,000
+59,000
| +94% | +$16.9M | 0.01% | 939 |
|
|
2019
Q2 | $18.5M | Sell |
63,000
-6,200
| -9% | -$1.71M | 0.01% | 1333 |
|
|
2019
Q1 | $18.9M | Sell |
69,200
-140,000
| -67% | -$34.8M | 0.01% | 1242 |
|
|
2018
Q4 | $46.8M | Buy |
209,200
+68,200
| +48% | +$16M | 0.02% | 641 |
|
|
2018
Q3 | $34.4M | Sell |
141,000
-11,100
| -7% | -$2.55M | 0.01% | 905 |
|
|
2018
Q2 | $31.5M | Sell |
152,100
-80,700
| -35% | -$17.1M | 0.01% | 956 |
|
|
2018
Q1 | $48.1M | Sell |
232,800
-38,400
| -14% | -$8.06M | 0.02% | 687 |
|
|
2017
Q4 | $51.5M | Buy |
271,200
+60,700
| +29% | +$11.6M | 0.02% | 681 |
|
|
2017
Q3 | $39.8M | Buy |
210,500
+91,000
| +76% | +$16.5M | 0.02% | 753 |
|
|
2017
Q2 | $20.8M | Sell |
119,500
-6,200
| -5% | -$1.04M | 0.01% | 1144 |
|
|
2017
Q1 | $19.3M | Sell |
125,700
-41,400
| -25% | -$6.33M | 0.01% | 1095 |
|
|
2016
Q4 | $23.6M | Buy |
167,100
+28,000
| +20% | +$4.13M | 0.01% | 928 |
|
|
2016
Q3 | $22.1M | Buy |
139,100
+50,000
| +56% | +$7.7M | 0.01% | 944 |
|
|
2016
Q2 | $13.2M | Buy |
89,100
+5,900
| +7% | +$871K | 0.01% | 1235 |
|
|
2016
Q1 | $11.8M | Sell |
83,200
-33,200
| -29% | -$4.45M | 0.01% | 1401 |
|
|
2015
Q4 | $16.5M | Sell |
116,400
-39,300
| -25% | -$5.24M | 0.01% | 1291 |
|
|
2015
Q3 | $19M | Buy |
155,700
+31,200
| +25% | +$4.06M | 0.01% | 1244 |
|
|
2015
Q2 | $16.2M | Buy |
124,500
+17,400
| +16% | +$2.27M | 0.01% | 1514 |
|
|
2015
Q1 | $14.4M | Sell |
107,100
-94,600
| -47% | -$12.2M | 0.01% | 1525 |
|
|
2014
Q4 | $25.3M | Sell |
201,700
-18,100
| -8% | -$2.2M | 0.01% | 1166 |
|
|
2014
Q3 | $26.8M | Buy |
219,800
+84,500
| +62% | +$10.3M | 0.01% | 1160 |
|
|
2014
Q2 | $16M | Sell |
135,300
-76,000
| -36% | -$8.94M | 0.01% | 1600 |
|
|
2014
Q1 | $25.4M | Sell |
211,300
-210,500
| -50% | -$25M | 0.01% | 1080 |
|
|
2013
Q4 | $47M | Buy |
421,800
+63,000
| +18% | +$6.26M | 0.02% | 701 |
|
|
2013
Q3 | $33.1M | Buy |
358,800
+240,400
| +203% | +$21.7M | 0.02% | 843 |
|
|
2013
Q2 | $10M | Buy |
+118,400
| New | +$9.86M | 0.01% | 1790 |
|
Other funds holding TMO
VCM
Susquehanna International Group's TMO Position: Q1 2026 in Review
Susquehanna International Group reduced its Thermo Fisher Scientific (TMO) stake by 67% in Q1 2026, selling an estimated $70.1M and leaving 64,399 shares worth $31.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1681.
Susquehanna International Group first reported a position in TMO in Q2 2013 and has held it in 47 quarters since. The position peaked at $144M in Q4 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Susquehanna International Group held 64,399 shares of Thermo Fisher Scientific worth $31.7M as of Q1 2026.
- Susquehanna International Group sold 129,156 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.1M.
- Thermo Fisher Scientific made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1681 holding.
- Susquehanna International Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 47 quarters since.
- Susquehanna International Group's Thermo Fisher Scientific position peaked at $144M in Q4 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.